HPV infection and EGFR activation/alteration in HIV-infected East African patients with conjunctival carcinoma

PLoS ONE

Volumn 5, Issue 5, 2010, Pages

  Yu, Jing Jie ^a   Fu, Pingfu ^b   Pink, John J ^b   Dawson, Dawn ^b   Wasman, Jay ^b   Orem, Jackson ^c   Mwanda, Walter O ^d   Zhu, Honglan ^a,f   Liang, Xiaobing ^a   Guo, Yi ^a   Petros, William P ^a   Mitsuyasu, Ronald T ^e   Wabinga, Henry ^c   Remick, Scot C ^a  

^a WEST VIRGINIA UNIVERSITY   (United States)

^b CASE WESTERN RESERVE UNIVERSITY   (United States)

^c MAKERERE UNIVERSITY   (Uganda)

^d UNIVERSITY OF NAIROBI   (Kenya)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f PEKING UNIVERSITY PEOPLE S HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN KINASE B; VIRUS DNA;

AFRICA; ARTICLE; CANCER INVASION; CONJUNCTIVA TUMOR; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; DNA SEQUENCE; EYE CANCER; GENE EXPRESSION; GENOTYPE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MISSENSE MUTATION; MUTATIONAL ANALYSIS; NONHUMAN; PAPILLOMAVIRUS INFECTION; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; RECEPTOR UPREGULATION; SIGNAL TRANSDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM; SQUAMOUS CELL CARCINOMA; VIRUS CLASSIFICATION; VIRUS DETECTION;

AFRICA, EASTERN; CARCINOMA IN SITU; CONJUNCTIVAL NEOPLASMS; DISEASE PROGRESSION; ENZYME ACTIVATION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HIV; HIV INFECTIONS; HUMANS; MALE; MITOGEN-ACTIVATED PROTEIN KINASES; MUTATION; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PREVALENCE; PROTO-ONCOGENE PROTEINS C-AKT; RECEPTOR, EPIDERMAL GROWTH FACTOR; RNA, MESSENGER; SIGNAL TRANSDUCTION;

HUMAN PAPILLOMAVIRUS; HUMAN PAPILLOMAVIRUS TYPE 16;

EID: 77956503393     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0010477     Document Type: Article

References (31)

1. Orem J, Mwanda WO, Remick SC (2004) AIDS-associated cancer in developing nations. Curr Opin Oncol 16: 468-476.
2. Newton R, Ziegler J, Ateenyi-Agaba C, Bousarghin L, Casabonne D, et al. (2002) The epidemiology of conjunctival squamous cell carcinoma in Uganda. Br J Cancer 87: 301-308.
3. Ateenyi-Agaba C (1995) Conjunctival squamous cell carcinoma associated with HIV infection in Kampala, Uganda. Lancet 345: 695-696.
4. Waddell KM, Lewallen S, Lucas SB, Atenyi-Agaba C, Herrington CS, et al. (1996) Carcinoma of the conjunctiva and HIV infection in Uganda and Malawi. Br J Ophthalmol 80: 503-508.
5. Moubayed P, Mwakyoma H, Schneider DT (2004) High frequency of human papillomavirus 6/11, 16, and 18 infections in precancerous lesions and squamous cell carcinoma of the conjunctiva in subtropical Tanzania. Am J Clin Pathol 122: 938-943.
6. Muñoz N, Bosch FX, de Sanjosé S, Herrero R, Castellsagué X, et al. (2003) Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 348: 518-527.
7. Mork J, Lie AK, Glattre E, Hallmans G, Jellum E, et al. (2001) Human papillomavirus infection as a risk factor for squamous-cell carcinoma of the head and neck. N Engl J Med 344: 1125-1131.
8. Pim D, Collins M, Banks L (1992) Human papillomavirus type 16 E5 gene stimulates the transforming activity of the epidermal growth factor receptor. Oncogene 7: 27-32.
9. Stoppler MC, Straight SW, Tsao G, Schlegel R, McCance DJ (1996) The E5 gene of HPV-16 enhances keratinocyte immortalization by full-length DNA. Virology 223: 251-254.
10. Zhang B, Srirangam A, Potter DA, Roman A (2005) HPV16 E5 protein disrupts the c-Cbl-EGFR interaction and EGFR ubiquitination in human foreskin keratinocytes. Oncogene 24: 2585-2588.
11. Gu Z, Matlashewski G (1995) Effect of human papillomavirus type 16 oncogenes on MAP kinase activity. J Virol 69: 8051-8056.
12. Scheffner M, Werness BA, Huibregtse JM, Levine AJ, Howley PM (1990) The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53. Cell 63: 1129-1136.
13. Gonzalez SL, Stremlau M, He X, Basile JR, Munger K (2001) Degradation of the retinoblastoma tumor suppressor by the human papillomavirus type 16 E7 oncoprotein is important for functional inactivation and is separable from proteasomal degradation of E7. J Virol 75: 7583-7591.
14. Grunwald V, Hildago M (2003) Developing inhibitors of the epidermal growth factor receptor for cancer treatment. J Natl Cancer Inst 95: 851-867.
15. Begum S, Gillison ML, Nicol TL, Westra WH (2007) Detection of human papillomavirus-16 in fine-needle aspirates to determine tumor origin in patients with metastatic squamous cell carcinoma of the head and Neck. Clin Cancer Res 13: 1186-1191.
16. Kenny D, Shen L-P, Kolberg JA (2002) Detection of Viral Infection and Gene Expression in Clinical Tissue Specimens Using Branched DNA (bDNA) In Situ Hybridization. J Histochem Cytochem 50: 1219-1227.
17. Bertelsen BI, Kugarajh K, Skar R, Laerum OD (2006) HPV subtypes in cervical cancer biopsies between 1930 and 2004: detection using general primer pair PCR and sequencing. Virchows Arch 449: 141-147.
18. Ha PK, Pai SI, Westra WH, Gillison ML, Tong BC, et al. (2002) Real-time quantitative PCR demonstrates low prevalence of human papillomavirus type 16 in premalignant and malignant lesions of the oral cavity. Clin Cancer Res 8: 1203-1209.
19. Gillison ML (2006) Human papillomavirus and prognosis of oropharyngeal squamous cell carcinoma: implications for clinical research in head and neck cancers. J Clin Oncol 24: 5623-5625.
20. Aguilar LV, Lazcano-Ponce E, Vaccarella S, Cruz A, Herna'ndez P, et al. (2006) Human papillomavirus in men: comparison of different genital sites. Sex Transm Infect 82: 31-33.
21. Lindh M, Görander S, Andersson E, Horal P, Mattsby-Balzer I, et al. (2007) Real-time Taqman PCR targeting 14 human papilloma virus types. J Clin Virol 40: 321-324.
22. Lynch TJ, Bell DW, Sordella R, Gurubhagavatula S, Okimoto RA, et al. (2004) Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib. N Engl J Med 350: 2129-2139.
23. Jorissen RN, Walker F, Pouliot N, Garrett TP, Ward CW, et al. (2003) Epidermal growth factor receptor: mechanisms of activation and signaling. Exp Cell Res 284: 31-53.
24. Paez JG, Jänne PA, Lee JC, Tracy S, Greulich H, et al. (2004) EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy. Science 304: 1497-1500.
25. Shepler TR, Prieto VG, Diba R, Neuhaus RW, Shore JW, et al. (2006) Expression of the epidermal growth factor receptor in conjunctival squamous cell carcinoma. Ophthal Plast Reconstr Surg 22: 113-115.
26. Chen TP, Chen CM, Chang HW, Wang JS, Chang WC, et al. (2007) Increased expression of SKP2 and phospho-MAPK/ERK1/2 and decreased expression of p27 during tumor progression of cervical neoplasms. Gynecol Oncol 104: 516-523.
27. Kohrenhagen N, Voelker HU, Schmidt M, Kapp M, Krockenberger M, et al. (2008) Expression of transketolase-like 1 (TKTL1) and p-Akt correlates with the progression of cervical neoplasia. J Obstet Gynaecol Res 34: 293-300.
28. de Koning MN, Waddell K, Magyezi J, Purdie K, Proby C, et al. (2008) Genital and cutaneous human papillomavirus (HPV) types in relation to conjunctival squamous cell neoplasia: a case-control study in Uganda. Infect Agent Cancer 3: 12.
29. Bosch FX, Manos MM, Muñoz N, Sherman M, Jansen AM, et al. (1995) Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International biological study on cervical cancer (IBSCC) Study Group. J Natl Cancer Inst 87: 796-802.
30. Sanclemente G, Gill DK (2002) Human papillomavirus molecular biology and pathogenesis. J Eur Acad Dermatol Venereol 16: 231-240.
31. Ferenczy A, Franco E (2002) Persistent human papillomavirus infection and cervical neoplasia. Lancet Oncol 3: 11-16.